FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2871307427> ?p ?o ?g. }

• W2871307427 endingPage "6735" @default.
• W2871307427 startingPage "6724" @default.
• W2871307427 abstract "The transcription factor RORγt is an attractive drug-target due to its role in the differentiation of IL-17 producing Th17 cells that play a critical role in the etiopathology of several autoimmune diseases. Identification of starting points for RORγt inverse agonists with good properties has been a challenge. We report the identification of a fragment hit and its conversion into a potent inverse agonist through fragment optimization, growing and merging efforts. Further analysis of the binding mode revealed that inverse agonism was achieved by an unusual mechanism. In contrast to other reported inverse agonists, there is no direct interaction or displacement of helix 12 observed in the crystal structure. Nevertheless, compound 9 proved to be efficacious in a delayed-type hypersensitivity (DTH) inflammation model in rats." @default.
• W2871307427 created "2018-07-19" @default.
• W2871307427 creator A5016690925 @default.
• W2871307427 creator A5020139373 @default.
• W2871307427 creator A5023570833 @default.
• W2871307427 creator A5024379262 @default.
• W2871307427 creator A5038950669 @default.
• W2871307427 creator A5039240269 @default.
• W2871307427 creator A5050799087 @default.
• W2871307427 creator A5050856589 @default.
• W2871307427 creator A5056071810 @default.
• W2871307427 creator A5059330877 @default.
• W2871307427 creator A5062566062 @default.
• W2871307427 creator A5062667085 @default.
• W2871307427 creator A5064974711 @default.
• W2871307427 creator A5070433531 @default.
• W2871307427 creator A5071832895 @default.
• W2871307427 creator A5072319898 @default.
• W2871307427 creator A5090423985 @default.
• W2871307427 date "2018-07-10" @default.
• W2871307427 modified "2023-10-03" @default.
• W2871307427 title "Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model" @default.
• W2871307427 cites W1829424643 @default.
• W2871307427 cites W1971126801 @default.
• W2871307427 cites W1980017607 @default.
• W2871307427 cites W1987161922 @default.
• W2871307427 cites W1999072167 @default.
• W2871307427 cites W2009701507 @default.
• W2871307427 cites W2019796661 @default.
• W2871307427 cites W2056048638 @default.
• W2871307427 cites W2064291209 @default.
• W2871307427 cites W2079953901 @default.
• W2871307427 cites W2084765237 @default.
• W2871307427 cites W2115908495 @default.
• W2871307427 cites W2141422737 @default.
• W2871307427 cites W2150309776 @default.
• W2871307427 cites W2201210340 @default.
• W2871307427 cites W2287583869 @default.
• W2871307427 cites W2515495491 @default.
• W2871307427 cites W2593499442 @default.
• W2871307427 cites W2621899512 @default.
• W2871307427 cites W2770913629 @default.
• W2871307427 cites W2771116143 @default.
• W2871307427 cites W2771231358 @default.
• W2871307427 cites W2785940728 @default.
• W2871307427 cites W2791903644 @default.
• W2871307427 doi "https://doi.org/10.1021/acs.jmedchem.8b00529" @default.
• W2871307427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29990434" @default.
• W2871307427 hasPublicationYear "2018" @default.
• W2871307427 type Work @default.
• W2871307427 sameAs 2871307427 @default.
• W2871307427 citedByCount "20" @default.
• W2871307427 countsByYear W28713074272019 @default.
• W2871307427 countsByYear W28713074272020 @default.
• W2871307427 countsByYear W28713074272021 @default.
• W2871307427 countsByYear W28713074272022 @default.
• W2871307427 countsByYear W28713074272023 @default.
• W2871307427 crossrefType "journal-article" @default.
• W2871307427 hasAuthorship W2871307427A5016690925 @default.
• W2871307427 hasAuthorship W2871307427A5020139373 @default.
• W2871307427 hasAuthorship W2871307427A5023570833 @default.
• W2871307427 hasAuthorship W2871307427A5024379262 @default.
• W2871307427 hasAuthorship W2871307427A5038950669 @default.
• W2871307427 hasAuthorship W2871307427A5039240269 @default.
• W2871307427 hasAuthorship W2871307427A5050799087 @default.
• W2871307427 hasAuthorship W2871307427A5050856589 @default.
• W2871307427 hasAuthorship W2871307427A5056071810 @default.
• W2871307427 hasAuthorship W2871307427A5059330877 @default.
• W2871307427 hasAuthorship W2871307427A5062566062 @default.
• W2871307427 hasAuthorship W2871307427A5062667085 @default.
• W2871307427 hasAuthorship W2871307427A5064974711 @default.
• W2871307427 hasAuthorship W2871307427A5070433531 @default.
• W2871307427 hasAuthorship W2871307427A5071832895 @default.
• W2871307427 hasAuthorship W2871307427A5072319898 @default.
• W2871307427 hasAuthorship W2871307427A5090423985 @default.
• W2871307427 hasConcept C104317684 @default.
• W2871307427 hasConcept C126322002 @default.
• W2871307427 hasConcept C150903083 @default.
• W2871307427 hasConcept C170493617 @default.
• W2871307427 hasConcept C185592680 @default.
• W2871307427 hasConcept C207001950 @default.
• W2871307427 hasConcept C207467116 @default.
• W2871307427 hasConcept C2524010 @default.
• W2871307427 hasConcept C2776914184 @default.
• W2871307427 hasConcept C2778938600 @default.
• W2871307427 hasConcept C33923547 @default.
• W2871307427 hasConcept C55493867 @default.
• W2871307427 hasConcept C71240020 @default.
• W2871307427 hasConcept C71924100 @default.
• W2871307427 hasConcept C74737994 @default.
• W2871307427 hasConcept C86339819 @default.
• W2871307427 hasConcept C86803240 @default.
• W2871307427 hasConcept C89951826 @default.
• W2871307427 hasConcept C98274493 @default.
• W2871307427 hasConceptScore W2871307427C104317684 @default.
• W2871307427 hasConceptScore W2871307427C126322002 @default.
• W2871307427 hasConceptScore W2871307427C150903083 @default.
• W2871307427 hasConceptScore W2871307427C170493617 @default.

• next